nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentostatin—Cladribine—hematologic cancer	0.212	1	CrCtD
Pentostatin—ADA—Nelarabine—hematologic cancer	0.146	1	CbGbCtD
Pentostatin—Nucleic Acid Synthesis Inhibitors—Nelarabine—hematologic cancer	0.116	0.308	CiPCiCtD
Pentostatin—Nucleic Acid Synthesis Inhibitors—Clofarabine—hematologic cancer	0.116	0.308	CiPCiCtD
Pentostatin—Nucleic Acid Synthesis Inhibitors—Cytarabine—hematologic cancer	0.0877	0.233	CiPCiCtD
Pentostatin—Nucleic Acid Synthesis Inhibitors—Gemcitabine—hematologic cancer	0.0565	0.15	CiPCiCtD
Pentostatin—Telbivudine—Cladribine—hematologic cancer	0.00909	0.0492	CrCrCtD
Pentostatin—Idoxuridine—Cladribine—hematologic cancer	0.00909	0.0492	CrCrCtD
Pentostatin—Trifluridine—Cladribine—hematologic cancer	0.00909	0.0492	CrCrCtD
Pentostatin—Floxuridine—Cladribine—hematologic cancer	0.00828	0.0448	CrCrCtD
Pentostatin—Azacitidine—Clofarabine—hematologic cancer	0.00773	0.0418	CrCrCtD
Pentostatin—Adenosine—Clofarabine—hematologic cancer	0.00773	0.0418	CrCrCtD
Pentostatin—Cladribine—Clofarabine—hematologic cancer	0.00773	0.0418	CrCrCtD
Pentostatin—Vidarabine—Clofarabine—hematologic cancer	0.00773	0.0418	CrCrCtD
Pentostatin—Decitabine—Clofarabine—hematologic cancer	0.00737	0.0398	CrCrCtD
Pentostatin—Adenosine—Nelarabine—hematologic cancer	0.00727	0.0393	CrCrCtD
Pentostatin—Cladribine—Nelarabine—hematologic cancer	0.00727	0.0393	CrCrCtD
Pentostatin—Vidarabine—Nelarabine—hematologic cancer	0.00727	0.0393	CrCrCtD
Pentostatin—Azacitidine—Nelarabine—hematologic cancer	0.00727	0.0393	CrCrCtD
Pentostatin—Decitabine—Nelarabine—hematologic cancer	0.00693	0.0375	CrCrCtD
Pentostatin—Vidarabine—Fludarabine—hematologic cancer	0.00568	0.0307	CrCrCtD
Pentostatin—Adenosine—Fludarabine—hematologic cancer	0.00568	0.0307	CrCrCtD
Pentostatin—Azacitidine—Fludarabine—hematologic cancer	0.00568	0.0307	CrCrCtD
Pentostatin—Cladribine—Fludarabine—hematologic cancer	0.00568	0.0307	CrCrCtD
Pentostatin—Azacitidine—Cytarabine—hematologic cancer	0.00536	0.029	CrCrCtD
Pentostatin—Adenosine—Cytarabine—hematologic cancer	0.00536	0.029	CrCrCtD
Pentostatin—Vidarabine—Cytarabine—hematologic cancer	0.00536	0.029	CrCrCtD
Pentostatin—Azacitidine—Gemcitabine—hematologic cancer	0.00536	0.029	CrCrCtD
Pentostatin—Adenosine—Cladribine—hematologic cancer	0.00522	0.0283	CrCrCtD
Pentostatin—Azacitidine—Cladribine—hematologic cancer	0.00522	0.0283	CrCrCtD
Pentostatin—Vidarabine—Cladribine—hematologic cancer	0.00522	0.0283	CrCrCtD
Pentostatin—Decitabine—Gemcitabine—hematologic cancer	0.00511	0.0276	CrCrCtD
Pentostatin—Decitabine—Cytarabine—hematologic cancer	0.00511	0.0276	CrCrCtD
Pentostatin—Decitabine—Cladribine—hematologic cancer	0.00498	0.0269	CrCrCtD
Pentostatin—ADA—Purine salvage—DCK—hematologic cancer	0.00162	0.0749	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—EVPL—hematologic cancer	0.00113	0.0522	CbGpPWpGaD
Pentostatin—ADA—Purine metabolism—GMPS—hematologic cancer	0.000961	0.0444	CbGpPWpGaD
Pentostatin—ADA—hematopoietic system—hematologic cancer	0.000877	0.261	CbGeAlD
Pentostatin—ADA—C-MYB transcription factor network—TOM1—hematologic cancer	0.000792	0.0366	CbGpPWpGaD
Pentostatin—ADA—Purine metabolism—DCK—hematologic cancer	0.000768	0.0355	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—PAX5—hematologic cancer	0.0006	0.0278	CbGpPWpGaD
Pentostatin—ADA—blood—hematologic cancer	0.000581	0.173	CbGeAlD
Pentostatin—ADA—bone marrow—hematologic cancer	0.000562	0.167	CbGeAlD
Pentostatin—ADA—C-MYB transcription factor network—LYZ—hematologic cancer	0.000511	0.0236	CbGpPWpGaD
Pentostatin—ADA—lung—hematologic cancer	0.000509	0.152	CbGeAlD
Pentostatin—ADA—Nucleotide metabolism—GMPS—hematologic cancer	0.000483	0.0223	CbGpPWpGaD
Pentostatin—ADA—testis—hematologic cancer	0.000481	0.143	CbGeAlD
Pentostatin—ADA—C-MYB transcription factor network—PRTN3—hematologic cancer	0.000455	0.021	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—PMAIP1—hematologic cancer	0.000393	0.0182	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—ANPEP—hematologic cancer	0.000387	0.0179	CbGpPWpGaD
Pentostatin—ADA—Nucleotide metabolism—DCK—hematologic cancer	0.000386	0.0179	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—hematologic cancer	0.00038	0.0176	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—CEBPD—hematologic cancer	0.000354	0.0164	CbGpPWpGaD
Pentostatin—ADA—lymph node—hematologic cancer	0.000348	0.104	CbGeAlD
Pentostatin—ADA—p73 transcription factor network—BAK1—hematologic cancer	0.000346	0.016	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—SPI1—hematologic cancer	0.000345	0.016	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—MAF—hematologic cancer	0.000345	0.016	CbGpPWpGaD
Pentostatin—ADA—Nucleotide metabolism—CDA—hematologic cancer	0.000335	0.0155	CbGpPWpGaD
Pentostatin—Azacitidine—DNMT3A—hematologic cancer	0.000289	0.234	CrCbGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—BBC3—hematologic cancer	0.000282	0.013	CbGpPWpGaD
Pentostatin—Decitabine—DNMT3A—hematologic cancer	0.000282	0.228	CrCbGaD
Pentostatin—ADA—p73 transcription factor network—GATA1—hematologic cancer	0.000274	0.0127	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—GATA1—hematologic cancer	0.000261	0.0121	CbGpPWpGaD
Pentostatin—Azacitidine—CDA—hematologic cancer	0.000257	0.209	CrCbGaD
Pentostatin—ADA—Circadian rythm related genes—PER3—hematologic cancer	0.000226	0.0105	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—LEF1—hematologic cancer	0.000226	0.0105	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CEBPD—hematologic cancer	0.000222	0.0103	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CEBPA—hematologic cancer	0.000222	0.0103	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CSF1R—hematologic cancer	0.000222	0.0103	CbGpPWpGaD
Pentostatin—Decitabine—DCK—hematologic cancer	0.000221	0.179	CrCbGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—hematologic cancer	0.000218	0.0101	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—OGG1—hematologic cancer	0.000215	0.00995	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—PML—hematologic cancer	0.000214	0.00989	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—BBC3—hematologic cancer	0.000208	0.00962	CbGpPWpGaD
Pentostatin—ADA—Nucleotide metabolism—TXN—hematologic cancer	0.0002	0.00927	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—hematologic cancer	0.0002	0.00924	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CRY2—hematologic cancer	0.000193	0.00891	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CRY1—hematologic cancer	0.000193	0.00891	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PER2—hematologic cancer	0.000193	0.00891	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CD34—hematologic cancer	0.000181	0.00838	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—WT1—hematologic cancer	0.000177	0.00818	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—MYB—hematologic cancer	0.000174	0.00807	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—BIRC3—hematologic cancer	0.000174	0.00807	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—NQO1—hematologic cancer	0.000173	0.00802	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—ID3—hematologic cancer	0.000164	0.00757	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—PML—hematologic cancer	0.000158	0.00729	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—HES1—hematologic cancer	0.000149	0.00691	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—MPO—hematologic cancer	0.000149	0.0069	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—KMT2A—hematologic cancer	0.000146	0.00675	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PER1—hematologic cancer	0.000146	0.00675	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—ABL1—hematologic cancer	0.000141	0.00654	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—GATA3—hematologic cancer	0.000135	0.00623	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—CDK6—hematologic cancer	0.000134	0.0062	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—TOP1—hematologic cancer	0.000133	0.00617	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—ID2—hematologic cancer	0.00013	0.00602	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—BAX—hematologic cancer	0.000129	0.00599	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDK6—hematologic cancer	0.000128	0.0059	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—FAS—hematologic cancer	0.000119	0.00551	CbGpPWpGaD
Pentostatin—Cladribine—DCK—hematologic cancer	0.000119	0.0965	CrCbGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—ATM—hematologic cancer	0.000118	0.00544	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—hematologic cancer	0.000113	0.00522	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—ABL1—hematologic cancer	0.000104	0.00482	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—ARNTL—hematologic cancer	0.000104	0.00481	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—KITLG—hematologic cancer	0.000102	0.0047	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—BAX—hematologic cancer	9.55e-05	0.00442	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—HES1—hematologic cancer	9.39e-05	0.00434	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—JAK1—hematologic cancer	9.35e-05	0.00433	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—GSTM1—hematologic cancer	9.33e-05	0.00432	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—NCOR1—hematologic cancer	9.33e-05	0.00432	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hematologic cancer	8.95e-05	0.00414	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—JUND—hematologic cancer	8.84e-05	0.00409	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—FAS—hematologic cancer	8.79e-05	0.00406	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—MDM2—hematologic cancer	8.68e-05	0.00402	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—CDK2—hematologic cancer	8.18e-05	0.00378	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—hematologic cancer	8.01e-05	0.00371	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CST3—hematologic cancer	7.94e-05	0.00367	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—MAPK14—hematologic cancer	7.85e-05	0.00363	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—MDM2—hematologic cancer	7.77e-05	0.00359	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PML—hematologic cancer	7.47e-05	0.00346	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—KIT—hematologic cancer	6.93e-05	0.00321	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—TOP2A—hematologic cancer	6.83e-05	0.00316	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—RB1—hematologic cancer	6.72e-05	0.00311	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN1A—hematologic cancer	6.55e-05	0.00303	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—EZH2—hematologic cancer	6.49e-05	0.003	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CREBBP—hematologic cancer	6.42e-05	0.00297	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—EP300—hematologic cancer	6.23e-05	0.00288	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—HDAC2—hematologic cancer	6.13e-05	0.00283	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—MDM2—hematologic cancer	5.73e-05	0.00265	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDKN2A—hematologic cancer	5.63e-05	0.0026	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—BCL2—hematologic cancer	5.54e-05	0.00256	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CD4—hematologic cancer	5.3e-05	0.00245	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDKN1B—hematologic cancer	4.98e-05	0.00231	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—CDKN1A—hematologic cancer	4.83e-05	0.00223	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CCND1—hematologic cancer	4.75e-05	0.0022	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—NCOR1—hematologic cancer	4.64e-05	0.00215	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDKN1A—hematologic cancer	4.6e-05	0.00213	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—EP300—hematologic cancer	4.6e-05	0.00213	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PRKCG—hematologic cancer	4.43e-05	0.00205	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GMPS—hematologic cancer	4.39e-05	0.00203	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PHYH—hematologic cancer	4.39e-05	0.00203	CbGpPWpGaD
Pentostatin—ADA—Metabolism—FTCD—hematologic cancer	4.39e-05	0.00203	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—EP300—hematologic cancer	4.38e-05	0.00202	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—FAS—hematologic cancer	4.16e-05	0.00193	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—NRAS—hematologic cancer	4.09e-05	0.00189	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SMPD3—hematologic cancer	4.01e-05	0.00186	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—MYC—hematologic cancer	4e-05	0.00185	CbGpPWpGaD
Pentostatin—Cladribine—SLC22A1—hematologic cancer	3.84e-05	0.0311	CrCbGaD
Pentostatin—ADA—C-MYB transcription factor network—MYC—hematologic cancer	3.81e-05	0.00176	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CDK4—hematologic cancer	3.66e-05	0.00169	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—KRAS—hematologic cancer	3.52e-05	0.00163	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ASNS—hematologic cancer	3.51e-05	0.00162	CbGpPWpGaD
Pentostatin—ADA—Metabolism—DCK—hematologic cancer	3.51e-05	0.00162	CbGpPWpGaD
Pentostatin—ADA—Metabolism—B3GAT1—hematologic cancer	3.51e-05	0.00162	CbGpPWpGaD
Pentostatin—ADA—Metabolism—HDC—hematologic cancer	3.32e-05	0.00154	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CREB1—hematologic cancer	3.28e-05	0.00152	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CDA—hematologic cancer	3.04e-05	0.00141	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—HRAS—hematologic cancer	2.99e-05	0.00139	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PC—hematologic cancer	2.93e-05	0.00135	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GBA—hematologic cancer	2.83e-05	0.00131	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SLC35B2—hematologic cancer	2.83e-05	0.00131	CbGpPWpGaD
Pentostatin—Cladribine—ABCG2—hematologic cancer	2.68e-05	0.0217	CrCbGaD
Pentostatin—ADA—Metabolism—MTAP—hematologic cancer	2.58e-05	0.0012	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—JUN—hematologic cancer	2.36e-05	0.00109	CbGpPWpGaD
Pentostatin—ADA—Metabolism—FHL2—hematologic cancer	2.3e-05	0.00107	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PTEN—hematologic cancer	2.28e-05	0.00106	CbGpPWpGaD
Pentostatin—ADA—Metabolism—AGRN—hematologic cancer	2.26e-05	0.00105	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—MAPK8—hematologic cancer	2.23e-05	0.00103	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—EP300—hematologic cancer	2.18e-05	0.00101	CbGpPWpGaD
Pentostatin—ADA—Metabolism—IDH2—hematologic cancer	2.14e-05	0.000991	CbGpPWpGaD
Pentostatin—ADA—Metabolism—HMMR—hematologic cancer	2.14e-05	0.000991	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ARNTL—hematologic cancer	2.01e-05	0.000932	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ACP5—hematologic cancer	1.96e-05	0.000906	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CA9—hematologic cancer	1.96e-05	0.000906	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NCOR2—hematologic cancer	1.93e-05	0.000894	CbGpPWpGaD
Pentostatin—ADA—Metabolism—IDH1—hematologic cancer	1.84e-05	0.000852	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTO1—hematologic cancer	1.82e-05	0.000843	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ABCC3—hematologic cancer	1.82e-05	0.000843	CbGpPWpGaD
Pentostatin—ADA—Metabolism—TXN—hematologic cancer	1.82e-05	0.000843	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SPHK1—hematologic cancer	1.78e-05	0.000824	CbGpPWpGaD
Pentostatin—ADA—Metabolism—UGT1A1—hematologic cancer	1.71e-05	0.000792	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SLC22A1—hematologic cancer	1.67e-05	0.000771	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CRABP1—hematologic cancer	1.67e-05	0.000771	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ALOX5—hematologic cancer	1.62e-05	0.000751	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NUP98—hematologic cancer	1.57e-05	0.000727	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—TP53—hematologic cancer	1.56e-05	0.000721	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ADCY7—hematologic cancer	1.53e-05	0.000706	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NCOA3—hematologic cancer	1.53e-05	0.000706	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NUP214—hematologic cancer	1.52e-05	0.000701	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ABCG2—hematologic cancer	1.48e-05	0.000687	CbGpPWpGaD
Pentostatin—ADA—Metabolism—MTR—hematologic cancer	1.48e-05	0.000687	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ENO2—hematologic cancer	1.46e-05	0.000674	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—IL6—hematologic cancer	1.43e-05	0.00066	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTT1—hematologic cancer	1.41e-05	0.000653	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SDC1—hematologic cancer	1.38e-05	0.000639	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NQO1—hematologic cancer	1.17e-05	0.000543	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CD44—hematologic cancer	1.17e-05	0.000543	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CYCS—hematologic cancer	1.11e-05	0.000514	CbGpPWpGaD
Pentostatin—ADA—Metabolism—HSP90AA1—hematologic cancer	1.1e-05	0.00051	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTP1—hematologic cancer	9.79e-06	0.000453	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ABCB1—hematologic cancer	9.27e-06	0.000429	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTM1—hematologic cancer	8.99e-06	0.000416	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NCOR1—hematologic cancer	8.99e-06	0.000416	CbGpPWpGaD
Pentostatin—ADA—Metabolism—MTHFR—hematologic cancer	7.95e-06	0.000368	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PIK3CG—hematologic cancer	6.68e-06	0.000309	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CREBBP—hematologic cancer	6.19e-06	0.000286	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PIK3CD—hematologic cancer	5.87e-06	0.000272	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ALB—hematologic cancer	5.8e-06	0.000268	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PIK3R1—hematologic cancer	5.54e-06	0.000256	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PIK3CB—hematologic cancer	5.12e-06	0.000237	CbGpPWpGaD
Pentostatin—Oedema peripheral—Doxorubicin—hematologic cancer	5.09e-06	9.08e-05	CcSEcCtD
Pentostatin—Asthenia—Etoposide—hematologic cancer	5.08e-06	9.06e-05	CcSEcCtD
Pentostatin—Body temperature increased—Triamcinolone—hematologic cancer	5.08e-06	9.05e-05	CcSEcCtD
Pentostatin—Decreased appetite—Dexamethasone—hematologic cancer	5.07e-06	9.03e-05	CcSEcCtD
Pentostatin—Decreased appetite—Betamethasone—hematologic cancer	5.07e-06	9.03e-05	CcSEcCtD
Pentostatin—Nausea—Irinotecan—hematologic cancer	5.06e-06	9.02e-05	CcSEcCtD
Pentostatin—Nausea—Mitoxantrone—hematologic cancer	5.06e-06	9.02e-05	CcSEcCtD
Pentostatin—Infection—Prednisone—hematologic cancer	5.04e-06	8.99e-05	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.03e-06	8.97e-05	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.03e-06	8.97e-05	CcSEcCtD
Pentostatin—Fatigue—Dexamethasone—hematologic cancer	5.03e-06	8.96e-05	CcSEcCtD
Pentostatin—Fatigue—Betamethasone—hematologic cancer	5.03e-06	8.96e-05	CcSEcCtD
Pentostatin—Chills—Epirubicin—hematologic cancer	5.01e-06	8.94e-05	CcSEcCtD
Pentostatin—Pruritus—Etoposide—hematologic cancer	5.01e-06	8.93e-05	CcSEcCtD
Pentostatin—Shock—Prednisone—hematologic cancer	4.99e-06	8.9e-05	CcSEcCtD
Pentostatin—Arrhythmia—Epirubicin—hematologic cancer	4.99e-06	8.9e-05	CcSEcCtD
Pentostatin—Pain—Betamethasone—hematologic cancer	4.98e-06	8.89e-05	CcSEcCtD
Pentostatin—Pain—Dexamethasone—hematologic cancer	4.98e-06	8.89e-05	CcSEcCtD
Pentostatin—Visual impairment—Doxorubicin—hematologic cancer	4.98e-06	8.88e-05	CcSEcCtD
Pentostatin—Nervous system disorder—Prednisone—hematologic cancer	4.98e-06	8.87e-05	CcSEcCtD
Pentostatin—Tachycardia—Prednisone—hematologic cancer	4.95e-06	8.83e-05	CcSEcCtD
Pentostatin—Alopecia—Epirubicin—hematologic cancer	4.94e-06	8.8e-05	CcSEcCtD
Pentostatin—Skin disorder—Prednisone—hematologic cancer	4.93e-06	8.79e-05	CcSEcCtD
Pentostatin—Nausea—Gemcitabine—hematologic cancer	4.93e-06	8.78e-05	CcSEcCtD
Pentostatin—Vomiting—Cisplatin—hematologic cancer	4.92e-06	8.76e-05	CcSEcCtD
Pentostatin—Hyperhidrosis—Prednisone—hematologic cancer	4.91e-06	8.75e-05	CcSEcCtD
Pentostatin—Rash—Cisplatin—hematologic cancer	4.87e-06	8.69e-05	CcSEcCtD
Pentostatin—Dermatitis—Cisplatin—hematologic cancer	4.87e-06	8.68e-05	CcSEcCtD
Pentostatin—Diarrhoea—Etoposide—hematologic cancer	4.85e-06	8.64e-05	CcSEcCtD
Pentostatin—Anorexia—Prednisone—hematologic cancer	4.84e-06	8.63e-05	CcSEcCtD
Pentostatin—Tinnitus—Doxorubicin—hematologic cancer	4.82e-06	8.59e-05	CcSEcCtD
Pentostatin—Anaemia—Methotrexate—hematologic cancer	4.8e-06	8.56e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Betamethasone—hematologic cancer	4.8e-06	8.56e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Dexamethasone—hematologic cancer	4.8e-06	8.56e-05	CcSEcCtD
Pentostatin—Flatulence—Epirubicin—hematologic cancer	4.79e-06	8.55e-05	CcSEcCtD
Pentostatin—Tension—Epirubicin—hematologic cancer	4.77e-06	8.51e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Betamethasone—hematologic cancer	4.77e-06	8.5e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.77e-06	8.5e-05	CcSEcCtD
Pentostatin—Hypersensitivity—Triamcinolone—hematologic cancer	4.73e-06	8.44e-05	CcSEcCtD
Pentostatin—Nervousness—Epirubicin—hematologic cancer	4.72e-06	8.42e-05	CcSEcCtD
Pentostatin—Dizziness—Etoposide—hematologic cancer	4.68e-06	8.35e-05	CcSEcCtD
Pentostatin—Vertigo—Methotrexate—hematologic cancer	4.67e-06	8.33e-05	CcSEcCtD
Pentostatin—Leukopenia—Methotrexate—hematologic cancer	4.65e-06	8.29e-05	CcSEcCtD
Pentostatin—Chills—Doxorubicin—hematologic cancer	4.64e-06	8.27e-05	CcSEcCtD
Pentostatin—Urticaria—Dexamethasone—hematologic cancer	4.63e-06	8.25e-05	CcSEcCtD
Pentostatin—Urticaria—Betamethasone—hematologic cancer	4.63e-06	8.25e-05	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.63e-06	8.24e-05	CcSEcCtD
Pentostatin—Dizziness—Prednisolone—hematologic cancer	4.62e-06	8.23e-05	CcSEcCtD
Pentostatin—Arrhythmia—Doxorubicin—hematologic cancer	4.62e-06	8.23e-05	CcSEcCtD
Pentostatin—Asthenia—Triamcinolone—hematologic cancer	4.61e-06	8.22e-05	CcSEcCtD
Pentostatin—Body temperature increased—Betamethasone—hematologic cancer	4.61e-06	8.21e-05	CcSEcCtD
Pentostatin—Abdominal pain—Betamethasone—hematologic cancer	4.61e-06	8.21e-05	CcSEcCtD
Pentostatin—Body temperature increased—Dexamethasone—hematologic cancer	4.61e-06	8.21e-05	CcSEcCtD
Pentostatin—Abdominal pain—Dexamethasone—hematologic cancer	4.61e-06	8.21e-05	CcSEcCtD
Pentostatin—Nausea—Cisplatin—hematologic cancer	4.59e-06	8.19e-05	CcSEcCtD
Pentostatin—Insomnia—Prednisone—hematologic cancer	4.59e-06	8.18e-05	CcSEcCtD
Pentostatin—Alopecia—Doxorubicin—hematologic cancer	4.57e-06	8.15e-05	CcSEcCtD
Pentostatin—Paraesthesia—Prednisone—hematologic cancer	4.56e-06	8.13e-05	CcSEcCtD
Pentostatin—Pruritus—Triamcinolone—hematologic cancer	4.55e-06	8.1e-05	CcSEcCtD
Pentostatin—Cough—Methotrexate—hematologic cancer	4.54e-06	8.09e-05	CcSEcCtD
Pentostatin—Convulsion—Methotrexate—hematologic cancer	4.5e-06	8.03e-05	CcSEcCtD
Pentostatin—Vomiting—Etoposide—hematologic cancer	4.5e-06	8.03e-05	CcSEcCtD
Pentostatin—Anaemia—Epirubicin—hematologic cancer	4.5e-06	8.02e-05	CcSEcCtD
Pentostatin—Agitation—Epirubicin—hematologic cancer	4.47e-06	7.97e-05	CcSEcCtD
Pentostatin—Dyspepsia—Prednisone—hematologic cancer	4.47e-06	7.97e-05	CcSEcCtD
Pentostatin—Rash—Etoposide—hematologic cancer	4.47e-06	7.96e-05	CcSEcCtD
Pentostatin—Dermatitis—Etoposide—hematologic cancer	4.46e-06	7.95e-05	CcSEcCtD
Pentostatin—Headache—Etoposide—hematologic cancer	4.44e-06	7.91e-05	CcSEcCtD
Pentostatin—Flatulence—Doxorubicin—hematologic cancer	4.44e-06	7.91e-05	CcSEcCtD
Pentostatin—Arthralgia—Methotrexate—hematologic cancer	4.43e-06	7.89e-05	CcSEcCtD
Pentostatin—Chest pain—Methotrexate—hematologic cancer	4.43e-06	7.89e-05	CcSEcCtD
Pentostatin—Myalgia—Methotrexate—hematologic cancer	4.43e-06	7.89e-05	CcSEcCtD
Pentostatin—ADA—Metabolism—PTEN—hematologic cancer	4.42e-06	0.000205	CbGpPWpGaD
Pentostatin—Tension—Doxorubicin—hematologic cancer	4.42e-06	7.87e-05	CcSEcCtD
Pentostatin—Decreased appetite—Prednisone—hematologic cancer	4.41e-06	7.87e-05	CcSEcCtD
Pentostatin—Rash—Prednisolone—hematologic cancer	4.4e-06	7.85e-05	CcSEcCtD
Pentostatin—Dermatitis—Prednisolone—hematologic cancer	4.4e-06	7.84e-05	CcSEcCtD
Pentostatin—Fatigue—Prednisone—hematologic cancer	4.38e-06	7.8e-05	CcSEcCtD
Pentostatin—Headache—Prednisolone—hematologic cancer	4.38e-06	7.8e-05	CcSEcCtD
Pentostatin—Nervousness—Doxorubicin—hematologic cancer	4.37e-06	7.79e-05	CcSEcCtD
Pentostatin—Vertigo—Epirubicin—hematologic cancer	4.37e-06	7.79e-05	CcSEcCtD
Pentostatin—Syncope—Epirubicin—hematologic cancer	4.36e-06	7.78e-05	CcSEcCtD
Pentostatin—Leukopenia—Epirubicin—hematologic cancer	4.35e-06	7.76e-05	CcSEcCtD
Pentostatin—Constipation—Prednisone—hematologic cancer	4.34e-06	7.74e-05	CcSEcCtD
Pentostatin—Confusional state—Methotrexate—hematologic cancer	4.28e-06	7.63e-05	CcSEcCtD
Pentostatin—Loss of consciousness—Epirubicin—hematologic cancer	4.28e-06	7.62e-05	CcSEcCtD
Pentostatin—Dizziness—Triamcinolone—hematologic cancer	4.25e-06	7.57e-05	CcSEcCtD
Pentostatin—Cough—Epirubicin—hematologic cancer	4.25e-06	7.57e-05	CcSEcCtD
Pentostatin—ADA—Metabolism—EP300—hematologic cancer	4.22e-06	0.000195	CbGpPWpGaD
Pentostatin—Convulsion—Epirubicin—hematologic cancer	4.22e-06	7.51e-05	CcSEcCtD
Pentostatin—Infection—Methotrexate—hematologic cancer	4.21e-06	7.51e-05	CcSEcCtD
Pentostatin—Nausea—Etoposide—hematologic cancer	4.21e-06	7.5e-05	CcSEcCtD
Pentostatin—Hypertension—Epirubicin—hematologic cancer	4.2e-06	7.49e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Prednisone—hematologic cancer	4.18e-06	7.46e-05	CcSEcCtD
Pentostatin—Asthenia—Betamethasone—hematologic cancer	4.18e-06	7.46e-05	CcSEcCtD
Pentostatin—Asthenia—Dexamethasone—hematologic cancer	4.18e-06	7.46e-05	CcSEcCtD
Pentostatin—Nervous system disorder—Methotrexate—hematologic cancer	4.16e-06	7.42e-05	CcSEcCtD
Pentostatin—Anaemia—Doxorubicin—hematologic cancer	4.16e-06	7.42e-05	CcSEcCtD
Pentostatin—Thrombocytopenia—Methotrexate—hematologic cancer	4.15e-06	7.4e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Prednisone—hematologic cancer	4.15e-06	7.4e-05	CcSEcCtD
Pentostatin—Nausea—Prednisolone—hematologic cancer	4.15e-06	7.4e-05	CcSEcCtD
Pentostatin—Myalgia—Epirubicin—hematologic cancer	4.14e-06	7.38e-05	CcSEcCtD
Pentostatin—Chest pain—Epirubicin—hematologic cancer	4.14e-06	7.38e-05	CcSEcCtD
Pentostatin—Arthralgia—Epirubicin—hematologic cancer	4.14e-06	7.38e-05	CcSEcCtD
Pentostatin—Agitation—Doxorubicin—hematologic cancer	4.14e-06	7.37e-05	CcSEcCtD
Pentostatin—Anxiety—Epirubicin—hematologic cancer	4.13e-06	7.36e-05	CcSEcCtD
Pentostatin—Pruritus—Betamethasone—hematologic cancer	4.12e-06	7.35e-05	CcSEcCtD
Pentostatin—Pruritus—Dexamethasone—hematologic cancer	4.12e-06	7.35e-05	CcSEcCtD
Pentostatin—Skin disorder—Methotrexate—hematologic cancer	4.12e-06	7.35e-05	CcSEcCtD
Pentostatin—Hyperhidrosis—Methotrexate—hematologic cancer	4.1e-06	7.31e-05	CcSEcCtD
Pentostatin—Vomiting—Triamcinolone—hematologic cancer	4.08e-06	7.28e-05	CcSEcCtD
Pentostatin—Rash—Triamcinolone—hematologic cancer	4.05e-06	7.22e-05	CcSEcCtD
Pentostatin—Dermatitis—Triamcinolone—hematologic cancer	4.05e-06	7.21e-05	CcSEcCtD
Pentostatin—Vertigo—Doxorubicin—hematologic cancer	4.04e-06	7.21e-05	CcSEcCtD
Pentostatin—Anorexia—Methotrexate—hematologic cancer	4.04e-06	7.21e-05	CcSEcCtD
Pentostatin—Syncope—Doxorubicin—hematologic cancer	4.04e-06	7.2e-05	CcSEcCtD
Pentostatin—Urticaria—Prednisone—hematologic cancer	4.03e-06	7.19e-05	CcSEcCtD
Pentostatin—Leukopenia—Doxorubicin—hematologic cancer	4.03e-06	7.18e-05	CcSEcCtD
Pentostatin—Headache—Triamcinolone—hematologic cancer	4.02e-06	7.17e-05	CcSEcCtD
Pentostatin—Abdominal pain—Prednisone—hematologic cancer	4.01e-06	7.15e-05	CcSEcCtD
Pentostatin—Body temperature increased—Prednisone—hematologic cancer	4.01e-06	7.15e-05	CcSEcCtD
Pentostatin—Confusional state—Epirubicin—hematologic cancer	4e-06	7.14e-05	CcSEcCtD
Pentostatin—Diarrhoea—Betamethasone—hematologic cancer	3.99e-06	7.11e-05	CcSEcCtD
Pentostatin—Diarrhoea—Dexamethasone—hematologic cancer	3.99e-06	7.11e-05	CcSEcCtD
Pentostatin—Hypotension—Methotrexate—hematologic cancer	3.96e-06	7.07e-05	CcSEcCtD
Pentostatin—Loss of consciousness—Doxorubicin—hematologic cancer	3.96e-06	7.05e-05	CcSEcCtD
Pentostatin—Infection—Epirubicin—hematologic cancer	3.94e-06	7.03e-05	CcSEcCtD
Pentostatin—Cough—Doxorubicin—hematologic cancer	3.93e-06	7e-05	CcSEcCtD
Pentostatin—Shock—Epirubicin—hematologic cancer	3.91e-06	6.96e-05	CcSEcCtD
Pentostatin—Convulsion—Doxorubicin—hematologic cancer	3.9e-06	6.95e-05	CcSEcCtD
Pentostatin—Nervous system disorder—Epirubicin—hematologic cancer	3.89e-06	6.94e-05	CcSEcCtD
Pentostatin—Thrombocytopenia—Epirubicin—hematologic cancer	3.89e-06	6.93e-05	CcSEcCtD
Pentostatin—Hypertension—Doxorubicin—hematologic cancer	3.89e-06	6.93e-05	CcSEcCtD
Pentostatin—Tachycardia—Epirubicin—hematologic cancer	3.87e-06	6.91e-05	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.87e-06	6.89e-05	CcSEcCtD
Pentostatin—Skin disorder—Epirubicin—hematologic cancer	3.86e-06	6.87e-05	CcSEcCtD
Pentostatin—Dizziness—Dexamethasone—hematologic cancer	3.85e-06	6.87e-05	CcSEcCtD
Pentostatin—Dizziness—Betamethasone—hematologic cancer	3.85e-06	6.87e-05	CcSEcCtD
Pentostatin—Hyperhidrosis—Epirubicin—hematologic cancer	3.84e-06	6.84e-05	CcSEcCtD
Pentostatin—Insomnia—Methotrexate—hematologic cancer	3.84e-06	6.84e-05	CcSEcCtD
Pentostatin—Myalgia—Doxorubicin—hematologic cancer	3.83e-06	6.83e-05	CcSEcCtD
Pentostatin—Chest pain—Doxorubicin—hematologic cancer	3.83e-06	6.83e-05	CcSEcCtD
Pentostatin—Arthralgia—Doxorubicin—hematologic cancer	3.83e-06	6.83e-05	CcSEcCtD
Pentostatin—Anxiety—Doxorubicin—hematologic cancer	3.82e-06	6.81e-05	CcSEcCtD
Pentostatin—Nausea—Triamcinolone—hematologic cancer	3.82e-06	6.8e-05	CcSEcCtD
Pentostatin—Paraesthesia—Methotrexate—hematologic cancer	3.81e-06	6.79e-05	CcSEcCtD
Pentostatin—Anorexia—Epirubicin—hematologic cancer	3.78e-06	6.75e-05	CcSEcCtD
Pentostatin—Dyspnoea—Methotrexate—hematologic cancer	3.78e-06	6.74e-05	CcSEcCtD
Pentostatin—Somnolence—Methotrexate—hematologic cancer	3.77e-06	6.72e-05	CcSEcCtD
Pentostatin—Hypersensitivity—Prednisone—hematologic cancer	3.74e-06	6.67e-05	CcSEcCtD
Pentostatin—Dyspepsia—Methotrexate—hematologic cancer	3.73e-06	6.66e-05	CcSEcCtD
Pentostatin—Hypotension—Epirubicin—hematologic cancer	3.71e-06	6.61e-05	CcSEcCtD
Pentostatin—Vomiting—Dexamethasone—hematologic cancer	3.71e-06	6.61e-05	CcSEcCtD
Pentostatin—Vomiting—Betamethasone—hematologic cancer	3.71e-06	6.61e-05	CcSEcCtD
Pentostatin—Confusional state—Doxorubicin—hematologic cancer	3.7e-06	6.6e-05	CcSEcCtD
Pentostatin—Decreased appetite—Methotrexate—hematologic cancer	3.69e-06	6.57e-05	CcSEcCtD
Pentostatin—Rash—Betamethasone—hematologic cancer	3.68e-06	6.55e-05	CcSEcCtD
Pentostatin—Rash—Dexamethasone—hematologic cancer	3.68e-06	6.55e-05	CcSEcCtD
Pentostatin—Dermatitis—Betamethasone—hematologic cancer	3.67e-06	6.55e-05	CcSEcCtD
Pentostatin—Dermatitis—Dexamethasone—hematologic cancer	3.67e-06	6.55e-05	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.66e-06	6.53e-05	CcSEcCtD
Pentostatin—Fatigue—Methotrexate—hematologic cancer	3.66e-06	6.52e-05	CcSEcCtD
Pentostatin—Headache—Dexamethasone—hematologic cancer	3.65e-06	6.51e-05	CcSEcCtD
Pentostatin—Headache—Betamethasone—hematologic cancer	3.65e-06	6.51e-05	CcSEcCtD
Pentostatin—Infection—Doxorubicin—hematologic cancer	3.65e-06	6.51e-05	CcSEcCtD
Pentostatin—Asthenia—Prednisone—hematologic cancer	3.64e-06	6.49e-05	CcSEcCtD
Pentostatin—Pain—Methotrexate—hematologic cancer	3.63e-06	6.47e-05	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.62e-06	6.45e-05	CcSEcCtD
Pentostatin—Shock—Doxorubicin—hematologic cancer	3.61e-06	6.44e-05	CcSEcCtD
Pentostatin—Nervous system disorder—Doxorubicin—hematologic cancer	3.6e-06	6.42e-05	CcSEcCtD
Pentostatin—Thrombocytopenia—Doxorubicin—hematologic cancer	3.6e-06	6.41e-05	CcSEcCtD
Pentostatin—Pruritus—Prednisone—hematologic cancer	3.59e-06	6.4e-05	CcSEcCtD
Pentostatin—Insomnia—Epirubicin—hematologic cancer	3.59e-06	6.4e-05	CcSEcCtD
Pentostatin—Tachycardia—Doxorubicin—hematologic cancer	3.59e-06	6.39e-05	CcSEcCtD
Pentostatin—Skin disorder—Doxorubicin—hematologic cancer	3.57e-06	6.36e-05	CcSEcCtD
Pentostatin—Paraesthesia—Epirubicin—hematologic cancer	3.57e-06	6.36e-05	CcSEcCtD
Pentostatin—Hyperhidrosis—Doxorubicin—hematologic cancer	3.55e-06	6.33e-05	CcSEcCtD
Pentostatin—Dyspnoea—Epirubicin—hematologic cancer	3.54e-06	6.31e-05	CcSEcCtD
Pentostatin—Somnolence—Epirubicin—hematologic cancer	3.53e-06	6.29e-05	CcSEcCtD
Pentostatin—Anorexia—Doxorubicin—hematologic cancer	3.5e-06	6.24e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Methotrexate—hematologic cancer	3.5e-06	6.23e-05	CcSEcCtD
Pentostatin—Dyspepsia—Epirubicin—hematologic cancer	3.49e-06	6.23e-05	CcSEcCtD
Pentostatin—Diarrhoea—Prednisone—hematologic cancer	3.47e-06	6.19e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Methotrexate—hematologic cancer	3.47e-06	6.18e-05	CcSEcCtD
Pentostatin—Nausea—Betamethasone—hematologic cancer	3.46e-06	6.17e-05	CcSEcCtD
Pentostatin—Nausea—Dexamethasone—hematologic cancer	3.46e-06	6.17e-05	CcSEcCtD
Pentostatin—Decreased appetite—Epirubicin—hematologic cancer	3.45e-06	6.15e-05	CcSEcCtD
Pentostatin—Hypotension—Doxorubicin—hematologic cancer	3.43e-06	6.12e-05	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.43e-06	6.11e-05	CcSEcCtD
Pentostatin—Fatigue—Epirubicin—hematologic cancer	3.42e-06	6.1e-05	CcSEcCtD
Pentostatin—Pain—Epirubicin—hematologic cancer	3.4e-06	6.05e-05	CcSEcCtD
Pentostatin—Constipation—Epirubicin—hematologic cancer	3.4e-06	6.05e-05	CcSEcCtD
Pentostatin—Urticaria—Methotrexate—hematologic cancer	3.37e-06	6.01e-05	CcSEcCtD
Pentostatin—Dizziness—Prednisone—hematologic cancer	3.36e-06	5.98e-05	CcSEcCtD
Pentostatin—Abdominal pain—Methotrexate—hematologic cancer	3.35e-06	5.98e-05	CcSEcCtD
Pentostatin—Body temperature increased—Methotrexate—hematologic cancer	3.35e-06	5.98e-05	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.35e-06	5.97e-05	CcSEcCtD
Pentostatin—Insomnia—Doxorubicin—hematologic cancer	3.32e-06	5.92e-05	CcSEcCtD
Pentostatin—Paraesthesia—Doxorubicin—hematologic cancer	3.3e-06	5.88e-05	CcSEcCtD
Pentostatin—Dyspnoea—Doxorubicin—hematologic cancer	3.28e-06	5.84e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Epirubicin—hematologic cancer	3.27e-06	5.83e-05	CcSEcCtD
Pentostatin—Somnolence—Doxorubicin—hematologic cancer	3.27e-06	5.82e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Epirubicin—hematologic cancer	3.25e-06	5.79e-05	CcSEcCtD
Pentostatin—Dyspepsia—Doxorubicin—hematologic cancer	3.23e-06	5.76e-05	CcSEcCtD
Pentostatin—Vomiting—Prednisone—hematologic cancer	3.23e-06	5.75e-05	CcSEcCtD
Pentostatin—Rash—Prednisone—hematologic cancer	3.2e-06	5.71e-05	CcSEcCtD
Pentostatin—Dermatitis—Prednisone—hematologic cancer	3.2e-06	5.7e-05	CcSEcCtD
Pentostatin—Decreased appetite—Doxorubicin—hematologic cancer	3.19e-06	5.69e-05	CcSEcCtD
Pentostatin—Headache—Prednisone—hematologic cancer	3.18e-06	5.67e-05	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.17e-06	5.65e-05	CcSEcCtD
Pentostatin—Fatigue—Doxorubicin—hematologic cancer	3.17e-06	5.65e-05	CcSEcCtD
Pentostatin—Urticaria—Epirubicin—hematologic cancer	3.15e-06	5.62e-05	CcSEcCtD
Pentostatin—Pain—Doxorubicin—hematologic cancer	3.14e-06	5.6e-05	CcSEcCtD
Pentostatin—Constipation—Doxorubicin—hematologic cancer	3.14e-06	5.6e-05	CcSEcCtD
Pentostatin—Abdominal pain—Epirubicin—hematologic cancer	3.14e-06	5.59e-05	CcSEcCtD
Pentostatin—Body temperature increased—Epirubicin—hematologic cancer	3.14e-06	5.59e-05	CcSEcCtD
Pentostatin—Hypersensitivity—Methotrexate—hematologic cancer	3.13e-06	5.57e-05	CcSEcCtD
Pentostatin—ADA—Metabolism—PIK3CA—hematologic cancer	3.12e-06	0.000144	CbGpPWpGaD
Pentostatin—Asthenia—Methotrexate—hematologic cancer	3.04e-06	5.43e-05	CcSEcCtD
Pentostatin—Feeling abnormal—Doxorubicin—hematologic cancer	3.03e-06	5.4e-05	CcSEcCtD
Pentostatin—Nausea—Prednisone—hematologic cancer	3.02e-06	5.38e-05	CcSEcCtD
Pentostatin—Gastrointestinal pain—Doxorubicin—hematologic cancer	3e-06	5.35e-05	CcSEcCtD
Pentostatin—Pruritus—Methotrexate—hematologic cancer	3e-06	5.35e-05	CcSEcCtD
Pentostatin—Hypersensitivity—Epirubicin—hematologic cancer	2.93e-06	5.21e-05	CcSEcCtD
Pentostatin—Urticaria—Doxorubicin—hematologic cancer	2.92e-06	5.2e-05	CcSEcCtD
Pentostatin—Abdominal pain—Doxorubicin—hematologic cancer	2.9e-06	5.18e-05	CcSEcCtD
Pentostatin—Body temperature increased—Doxorubicin—hematologic cancer	2.9e-06	5.18e-05	CcSEcCtD
Pentostatin—Diarrhoea—Methotrexate—hematologic cancer	2.9e-06	5.17e-05	CcSEcCtD
Pentostatin—Asthenia—Epirubicin—hematologic cancer	2.85e-06	5.08e-05	CcSEcCtD
Pentostatin—Pruritus—Epirubicin—hematologic cancer	2.81e-06	5.01e-05	CcSEcCtD
Pentostatin—Dizziness—Methotrexate—hematologic cancer	2.81e-06	5e-05	CcSEcCtD
Pentostatin—Diarrhoea—Epirubicin—hematologic cancer	2.72e-06	4.84e-05	CcSEcCtD
Pentostatin—Hypersensitivity—Doxorubicin—hematologic cancer	2.71e-06	4.82e-05	CcSEcCtD
Pentostatin—Vomiting—Methotrexate—hematologic cancer	2.7e-06	4.81e-05	CcSEcCtD
Pentostatin—Rash—Methotrexate—hematologic cancer	2.68e-06	4.77e-05	CcSEcCtD
Pentostatin—Dermatitis—Methotrexate—hematologic cancer	2.67e-06	4.76e-05	CcSEcCtD
Pentostatin—Headache—Methotrexate—hematologic cancer	2.66e-06	4.74e-05	CcSEcCtD
Pentostatin—Asthenia—Doxorubicin—hematologic cancer	2.64e-06	4.7e-05	CcSEcCtD
Pentostatin—Dizziness—Epirubicin—hematologic cancer	2.63e-06	4.68e-05	CcSEcCtD
Pentostatin—Pruritus—Doxorubicin—hematologic cancer	2.6e-06	4.63e-05	CcSEcCtD
Pentostatin—ADA—Metabolism—AKT1—hematologic cancer	2.55e-06	0.000118	CbGpPWpGaD
Pentostatin—Vomiting—Epirubicin—hematologic cancer	2.52e-06	4.5e-05	CcSEcCtD
Pentostatin—Nausea—Methotrexate—hematologic cancer	2.52e-06	4.49e-05	CcSEcCtD
Pentostatin—Diarrhoea—Doxorubicin—hematologic cancer	2.51e-06	4.48e-05	CcSEcCtD
Pentostatin—Rash—Epirubicin—hematologic cancer	2.5e-06	4.46e-05	CcSEcCtD
Pentostatin—Dermatitis—Epirubicin—hematologic cancer	2.5e-06	4.46e-05	CcSEcCtD
Pentostatin—Headache—Epirubicin—hematologic cancer	2.49e-06	4.43e-05	CcSEcCtD
Pentostatin—Dizziness—Doxorubicin—hematologic cancer	2.43e-06	4.33e-05	CcSEcCtD
Pentostatin—Nausea—Epirubicin—hematologic cancer	2.36e-06	4.2e-05	CcSEcCtD
Pentostatin—Vomiting—Doxorubicin—hematologic cancer	2.34e-06	4.16e-05	CcSEcCtD
Pentostatin—Rash—Doxorubicin—hematologic cancer	2.32e-06	4.13e-05	CcSEcCtD
Pentostatin—Dermatitis—Doxorubicin—hematologic cancer	2.31e-06	4.13e-05	CcSEcCtD
Pentostatin—Headache—Doxorubicin—hematologic cancer	2.3e-06	4.1e-05	CcSEcCtD
Pentostatin—Nausea—Doxorubicin—hematologic cancer	2.18e-06	3.89e-05	CcSEcCtD
